Protecting the brain of the micropreemie

S M Boyd1, S J Tapawan2, N Badawi3

  • 1Grace Centre for Newborn Intensive Care, The Children's Hospital at Westmead, Sydney Children's Hospitals Network, Sydney, Australia; Specialty of Child & Adolescent Health, Sydney Medical School, Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia.

Insights

Protecting the extremely preterm infant brain is crucial. Evidence-based neuroprotection strategies, from prenatal care to neonatal interventions, aim to improve survival without disability and long-term quality of life.

Area of Science:

  • Neonatalogy and Perinatal Medicine
  • Developmental Neuroscience
  • Pediatric Neurology

Background:

  • Substantial improvements in survival rates for extremely preterm infants have been achieved.
  • Protecting the developing brain and mitigating neurodevelopmental sequelae are critical priorities.
  • Minimizing ischemia and inflammation is key to preventing brain injury, especially white matter damage.

Purpose of the Study:

  • To review evidence-based interventions for neuroprotection in extremely preterm infants.
  • To highlight the importance of avoiding complications that trigger brain injury.
  • To outline strategies for optimizing long-term outcomes through surveillance and early intervention.

Main Methods:

  • Review of existing evidence-based interventions for neuroprotection.
  • Discussion of strategies including prevention of preterm birth, antenatal care, and neonatal support.
  • Emphasis on avoiding ischemia and inflammation-inducing complications.

Main Results:

  • Multiple evidence-based interventions exist for neuroprotection in extremely preterm infants.
  • Antenatal care, optimized neonatal transition, and developmental care are crucial.
  • Avoiding complications like ischemia and inflammation is vital for brain development.

Conclusions:

  • Neurodevelopmental surveillance, early diagnosis, and intervention are essential for optimizing outcomes.
  • Further research is needed on neuroprotective agents and common neonatal interventions.
  • Improving neurodevelopmental outcomes in extremely preterm infants remains a key focus.